Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Abdominal Radiology (New York)|June 10, 2025
CT and MRI features of Catenin Beta 1-mutated hepatocellular carcinoma in a Western cohortWyanne Law, Junting Zheng, Tae-Hyung Kim, et al.
Cancer Medicine|April 3, 2021
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinomaJames J Harding, Richard K Do, Amin Yaqubie, et al.
JCO Oncology Practice|June 5, 2025
Automated Portal-Enabled Elicitation of Health-Related Patient Values in Solid Tumor Oncology: Feasibility and Patient Characteristics Associated With Patient ResponseAndrew S Epstein, Andrea Knezevic, Afshana Hoque, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2019
Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progressionAlessandra Borgheresi, Anne Covey, Hooman Yarmohammadi, et al.
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Cancer Medicine|February 25, 2022
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatmentDazhi Liu, Michael A Weintraub, Christine Garcia, et al.
Molecular Immunology|April 5, 2011
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levelsAndrew W Lee, Nan Wang, Tara M C Hornell, et al.
Journal of Gastrointestinal Oncology|June 11, 2016
Acute myeloid leukemia masquerading as hepatocellular carcinomaGhaith F Abu-Zeinah, Paul Weisman, Karuna Ganesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Human dendritic cell expression of HLA-DO is subset specific and regulated by maturationTara M C Hornell, Timo Burster, Frode L Jahnsen, et al.
Targeted Oncology|February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid TumorsJames J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Abdominal Radiology (New York)|June 10, 2025
CT and MRI features of Catenin Beta 1-mutated hepatocellular carcinoma in a Western cohortWyanne Law, Junting Zheng, Tae-Hyung Kim, et al.
Cancer Medicine|April 3, 2021
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinomaJames J Harding, Richard K Do, Amin Yaqubie, et al.
JCO Oncology Practice|June 5, 2025
Automated Portal-Enabled Elicitation of Health-Related Patient Values in Solid Tumor Oncology: Feasibility and Patient Characteristics Associated With Patient ResponseAndrew S Epstein, Andrea Knezevic, Afshana Hoque, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2019
Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progressionAlessandra Borgheresi, Anne Covey, Hooman Yarmohammadi, et al.
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Cancer Medicine|February 25, 2022
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatmentDazhi Liu, Michael A Weintraub, Christine Garcia, et al.
Molecular Immunology|April 5, 2011
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levelsAndrew W Lee, Nan Wang, Tara M C Hornell, et al.
Journal of Gastrointestinal Oncology|June 11, 2016
Acute myeloid leukemia masquerading as hepatocellular carcinomaGhaith F Abu-Zeinah, Paul Weisman, Karuna Ganesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Human dendritic cell expression of HLA-DO is subset specific and regulated by maturationTara M C Hornell, Timo Burster, Frode L Jahnsen, et al.
Targeted Oncology|February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid TumorsJames J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Pageof 14